Yarrow Bioscience (YARW) Exchange Rate Effect (2019 - 2021)
Yarrow Bioscience's (YARW) quarterly Exchange Rate Effect came in at -$1000.0 in Q2 2021, down 102.63% YoY from $38000.0 in Q2 2020, and down 200.0% on a QoQ basis from $1000.0 in Q1 2021.
Yarrow Bioscience (YARW) Exchange Rate Effect (2019 - 2021) Analysis & Trends
Yarrow Bioscience (YARW) has 3 years of Exchange Rate Effect data on file, last reported at -$1000.0 in Q2 2021.
- Quarterly Exchange Rate Effect fell 102.63% year-over-year to -$1000.0 in Q2 2021, while the trailing twelve-month figure through Mar 2022 was -$1000.0 (down 102.56% YoY) and the FY2020 annual result came in at $1000.0, down 97.56% from the prior year.
- Exchange Rate Effect slipped to -$1000.0 in Q2 2021, from $1000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $38000.0 in Q2 2020 to a low of -$37000.0 in Q1 2020.
- A 3-year average of $5250.0 and a median of $7000.0 in 2019 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2020 — Exchange Rate Effect tumbled 384.62% — and 2021, when it jumped 102.7%.
- Tracing YARW's Exchange Rate Effect over 3 years: stood at $16000.0 in 2019, then jumped by 137.5% to $38000.0 in 2020, then sank by 102.63% to -$1000.0 in 2021.
- The last three Exchange Rate Effect figures came in at -$1000.0 (Q2 2021), $1000.0 (Q1 2021), and $38000.0 (Q2 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -2.45 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -287,000.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.63 Mn |
| 10 | Yarrow Bioscience | 32.54 Mn | 9.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -1,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Jun 30, 2020 | 38,000.00 |
| Jun 30, 2020 | 38,000.00 |
| Mar 31, 2020 | -37,000.00 |
| Mar 31, 2020 | -37,000.00 |
| Dec 31, 2019 | 16,000.00 |
| Dec 31, 2019 | 16,000.00 |
| Sep 30, 2019 | -23,000.00 |
| Sep 30, 2019 | -23,000.00 |
| Jun 30, 2019 | 35,000.00 |
| Jun 30, 2019 | 35,000.00 |
| Mar 31, 2019 | 13,000.00 |
| Mar 31, 2019 | 13,000.00 |